Sponsor

E-DA Hospital

Clinical research sponsor

Published trials12

Recruiting shown2

Roles2

SourceClinicalTrials.gov

Clinical trials

12 shown

Risk Factors Affect Weight Loss Outcomes After Treatment.NCT06482411 · lead sponsor · 2024-06-27

COMPLETED

Naldebain for Pain Control After Bariatric SurgeryNCT04651361 · lead sponsor · 2021-06-24

UNKNOWN

Pulmonary Nodule Localization Prospective ValidationNCT04690790 · lead sponsor · 2021-01-23

UNKNOWN

The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer MonitoringNCT02437760 · lead sponsor · 2015-02-01

UNKNOWN

Taiwan Interstitial Lung Disease Multi-center Investigation and RegistryNCT06476470 · collaborator · 2024-03-10

RECRUITING

Taiwan Severe Asthma Biologic RegistryNCT06456450 · collaborator · 2023-11-11

RECRUITING

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfectionNCT03425994 · collaborator · 2018-02-06

UNKNOWN

The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral RegurgitationNCT04217135 · collaborator · 2017-01-01

UNKNOWN

Rosuvastatin Interethnic PK StudyNCT02215174 · collaborator · 2015-02-01

TERMINATED

A Prospective, Randomized Trial of Histoacryl Injection Versus Thrombin in the Control of Acute Gastric Variceal BleedingNCT01717612 · collaborator · 2012-10-01

UNKNOWN

Efficacy and Safety Study of Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) to Treat Type 2 Diabetes MellitusNCT01277900 · collaborator · 2011-01-01

UNKNOWN

Comparisons of Serologic Response of Early SyphilisNCT01944358 · collaborator · 2007-01-01

COMPLETED

Sponsor roles

collaborator8

lead sponsor4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.